ELOXX PHARMACEUTICALS, INC. Total Assets
ELOXX PHARMACEUTICALS, INC. (ELOX) had Total Assets of $63.39 million as of 2026-06-30, per its S-1 filed 2026-09-11.
Financial Statements › Balance Sheet › Assets
us-gaap:Assets · last filed 2026-09-11
- 2026-06-30: Assets $63.39M.
- 2026-03-31: Assets $8.50M.
- 2025-12-31: Assets $5.27M.
- 2024-12-31: Assets $2.98M.
| Period end | Assets | Assets as first filed |
|---|---|---|
| 2026-06-30 | $63.39M S-1 · filed 2026-09-11 | |
| 2026-03-31 | $8.50M S-1/A · filed 2026-06-04 | |
| 2025-12-31 | $5.27M S-1 · filed 2026-09-11 | |
| 2024-12-31 | $2.98M S-1 · filed 2026-09-11 | |
| 2023-12-31 | $1.71M S-1 · filed 2026-09-11 | |
| 2023-09-30 | $6.04M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $5.99M 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $7.20M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $21.12M 10-Q · filed 2023-11-13 | |
| 2022-09-30 | $26.88M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $32.94M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $43.62M 10-Q · filed 2022-05-06 | |
| 2021-12-31 | $45.14M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $55.38M 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $60.61M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $20.37M 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $26.48M 10-K · filed 2022-03-30 | |
| 2020-09-30 | $32.94M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $39.92M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $47.04M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $58.95M 10-K · filed 2021-03-12 | |
| 2019-09-30 | $68.06M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $79.04M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $56.89M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $50.72M 10-K · filed 2020-03-06 | |
| 2018-09-30 | $56.53M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $64.27M 10-Q · filed 2018-08-10 | |
| 2018-03-31 | $19.16M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $24.78M 10-K · filed 2019-03-14 | |
| 2017-09-30 | $6.59M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $5.85M 10-Q · filed 2017-11-14 | |
| 2017-03-31 | $5.84M 10-Q · filed 2017-05-22 | |
| 2016-12-31 | $3.13M 10-K · filed 2018-03-16 | $5.81M 10-Q · filed 2017-02-10 |
| 2016-09-30 | $7.01M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $9.23M 10-K · filed 2017-10-13 | |
| 2016-03-31 | $10.56M 10-Q · filed 2016-05-12 | |
| 2015-12-31 | $15.64M 10-Q · filed 2016-02-16 | |
| 2015-09-30 | $19.44M 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $19.55M 10-K · filed 2016-10-13 | |
| 2015-03-31 | $16.92M 10-Q · filed 2015-05-14 | |
| 2014-12-31 | $18.55M 10-Q · filed 2015-02-17 | |
| 2014-09-30 | $28.14M 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $33.33M 10-K · filed 2015-10-09 | |
| 2014-03-31 | $10.96M 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $11.10M 10-Q · filed 2014-02-14 | |
| 2013-09-30 | $5.81M 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $7.10M 10-K · filed 2014-09-29 | |
| 2013-03-31 | $6.89M 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $5.46M 10-Q · filed 2013-02-14 | |
| 2012-09-30 | $6.26M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $6.95M 10-K · filed 2013-09-11 | |
| 2012-03-31 | $8.63M 10-Q · filed 2012-05-14 | |
| 2011-12-31 | $6.86M 10-Q · filed 2012-02-14 | |
| 2011-09-30 | $8.27M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $8.60M 10-K/A · filed 2012-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Tevogen Inc. (TVGN) | United States | $0.049B |